Mr Mrs Miss Ms Dr Other

Ms
Punita
Shah

Patent Director

Manchester Office

Life sciences

Telephone. +44(0) 161 247 4900
Mobile. +44(0) 796 854 3578
Email. [email protected]

Experience

Punita's expertise lies predominantly in the area of biotechnology, with a specific focus on the technical fields of Agbio, diagnostics including point of care lateral flow tests, personalized medicine, biologics and gene therapy. Her experience also includes leading multi-disciplinary teams handling innovations which span the life sciences and electronics sectors. At both a personal and professional level, Punita is keenly interested in sustainable technology, in particular the ways in which the life sciences sector can improve sustainability to address key problems such as plastic pollution, packaging and the food industry.

Punita has worked extensively with multinational corporations, universities, and small to medium sized enterprises. She has a practical and commercially focused approach, and over the course of her career has assisted numerous small companies with IP portfolio management, with a focus toward building a robust patent strategy.

Punita is highly experienced in obtaining commercially valuable patent protection for her clients. Her practice includes routinely managing large global patent portfolios, as well as conducting due diligence to support corporate acquisition and investment, conducting freedom to operate analysis, and advising her clients on third party rights and infringement. Punita has defended her clients patent rights and commercial position in leading opposition and appeal proceedings before the EPO.

Qualifications

Patent Attorney

Chartered (UK)
Europe


MA

MA (Cantab) Natural Sciences

Publications

Healthcare and Climate Change

View publication online

Conferences: 2020

November 16th 2020

CIPA Life Sciences conference 2020

Attended

Related News

Managing Intellectual Property IP Stars 2023

After months of research, Managing IP has published the IP Stars list for 2023. HGF is delighted to have 23 attorneys from England, Scotland, Ireland, Netherlands and Germany recognised and …

Read article

Profiting from Innovation Within Product Platforms

Innovative businesses should seek to maximise the value they obtain from working collaboratively within a product platform ecosystem. A well-defined IP strategy can help achieve this while increasing total innovation …

Read article
Event - 25th May 2023

New seminar series in Salzburg, Dresden and Hamburg

HGF is organising a new German-speaking seminar series in Salzburg, Dresden, and Hamburg starting May 25 2023. Dates May 25, 2023 at 17:30 – Salzburg June 1 2023 at 17:30 …

Event details

Can Artificial Intelligence save the NHS?

In recent months, it has been almost impossible to escape reports of the staffing crisis in the NHS and the impact this is having on the services the NHS can …

Read article

Spotting innovation in digital health – and can you patent it?

Intellectual Property (IP) can add significant value to your business, providing a competitive edge over the market, as well as demonstrating sound business planning to help secure investment. There are …

Read article

Innovation at the heart of UK medtech strategy

The UK Department of Health and Social Care has recently published the government’s first ever medical technology strategy in an effort to accelerate access to innovative technologies. The strategy document …

Read article

How medtech start-ups can supercharge their IP for fundraising

Why is IP important for fundraising? Intellectual property (IP) rights underpin the value of most medtech start-up companies. IP rights include patents, design rights, trade marks, copyright and trade secrets …

Read article

What is EUDAMED and how will it affect your IP strategy?

The “European database on medical devices”, or “EUDAMED”, is the EU’s IT system created by the new Medical Devices Regulation (MDR) and In Vitro Diagnostics Medical Devices Regulation (IVDR). When …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.